Oct. 9, 2008 - ImmunoCellular Therapeutics, Ltd., a biotechnology company, announced the filing of a provisional U.S. patent application relating to its novel vaccine technology targeting cancer stem cells. The vaccine technology is exclusively licensed from Cedars-Sinai Medical Center.
The details can be read here.
No comments:
Post a Comment